Simacor 10 mg tablet

Simacor® Tablet : Each tablet contains Simvastatin USP 10 mg.

Primary hypercholesterolemia (type IIa and IIb) in patients who have notresponded adequately to diet and other appropriate measures.Coronary heart disease and elevated plasma cholesterol level.

The patient should be placed on a standard cholesterol lowering diet beforereceiving Simvastatin and should continue on this during treatment with Simvastatin. The usual starting dose is 10 mg/day given as a single dose in the evening. Adjustment of dosage, if required, should be made at intervals of not less than four weeks, to a maximum of 40 mg daily given as a single dose in the evening. If LDL-cholesterol levels fall below 2 mmol/L or total plasma cholesterol levels fall below 3.5 mmol/L consideration should be given to reducing the dose of Simvastatin. In hypercholesterolemia, the ecommended starting dose is 5-10 mg once a day in the evening and the recommended dosing range is 5-40 mg per day as a single dose in the evening. In patients with coronary heart disease and hypercholesterolemia,the starting dose should be 20 mg once a day in the evening. Because Simvastatin does not undergo significant renal excretion, modification of dosage should not be necessary in patients with renal insufficiency. Safety and effectiveness in children and adolescents have not been established.

Simvastatin is generally well tolerated. Headache, fatigue, insomnia,gastrointestinal effects like nausea, constipation or diarrhoea, flatulence,dyspepsia, abdominal cramps and muscular effects like myalgia, myositisand myopathy have been reported. Rare cases of rhabdomyolysis with acute renal failure secondary to myoglobinuria have been associated with Simvastatin therapy. Hepatitis, pancreatitis, rash, Angio-oedema have also been reported. No potentially life-threatening effects have been reported.